Therapeutic Asset Ratings

9,928 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
her2bbζ/cd19t+ t cells Leptomeningeal Melanoma	M.D. Anderson Cancer Center	P1	CC (43)
her2bbζ/cd19t+ t cells Glioma	City of Hope Medical Center	P1	CC (43)
her2bbζ/cd19t+ t cells Grade III Glioma	City of Hope Medical Center	P1	CC (43)
HER2(EQ)BBzeta Glioma	City of Hope Medical Center	P1	CC (43)
HER2(EQ)BBzeta Grade III Glioma	City of Hope Medical Center	P1	CC (43)
H-Gamma1 Heavy Chain Humanized (1-449) [Vh (Homo Sapiens Ighv3-2301 (81.6%) -(Ighd) -Ighj302 (91.7%) M123>T (114), Cdr-Imgt [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo Sapiens Ighg103V (100%) G1M3>G1M17, Ng1M1 Ch1 K120, Ch3 E12, M14 (Ch1 R120>K (216) (120-217), Hinge 1-15 (218-232), Ch2 (233-342), Ch3 E12 (358), M14 (360) (343-447), Chs (448-449)) (120-449)], (222-218')-Disulfide With L-Kappa Light Chain Humanized (1'-218') [Vkappa (Homo Sapiens Igkv1-3301 (87.8%) -Igkj401 (100%), Cdr-Imgt [6.3.13] (27'-32'.50'-52'.89'-101')) (1'-111')-Homo Sapiens Igkc01 (100%) Km3 A45.1, V101 (C-Kappaa45.1 (157'), V101 (195')) (112'-218')]; Dimer (228-228'':231-231'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa Nonpapillary Renal Cell Carcinoma	Genentech, Inc.	P1	CC (43)
Hidac Acute Myeloid Leukemia	Syndax Pharmaceuticals	P1	CC (43)
hlx18 Gastroesophageal Cancer	Shanghai Henlius Biotech	P1	CC (43)
hlx35 Non-Small Cell Squamous Lung Carcinoma	Shanghai Henlius Biotech	P1	CC (43)
Hmi-103 Phenylketonuria	Homology Medicines, Inc	P1	CC (43)
Hmpl-760 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Hutchmed	P1	CC (43)
Hmpl-760 Diffuse Large B-Cell Lymphoma	Hutchmed	P1	CC (43)
Hmpl-760 Mantle Cell Lymphoma	Hutchmed	P1	CC (43)
Hmpl-760 Marginal Zone Lymphoma	Hutchmed	P1	CC (43)
Hmpl-760 Non-Hodgkin Lymphoma	Hutchmed	P1	CC (43)
Hnpc01 Ischemic Stroke	Hopstem Biotechnology Inc.	P1	CC (43)
hro761 Cancer	Novartis Pharmaceuticals	P1	CC (43)
Hrs-2189 Cancer	Shandong Suncadia Medicine Co., Ltd.	P1	CC (43)
hrs8807 Breast Carcinoma	Shanghai Hengrui Pharmaceutical Co., Ltd.	P1	CC (43)
Hryz-T101 Penile Carcinoma	HRYZ Biotech Co.	P1	CC (43)
Hryz-T101 Vaginal Carcinoma	HRYZ Biotech Co.	P1	CC (43)
Hryz-T101 Vulvar Carcinoma	HRYZ Biotech Co.	P1	CC (43)
Hryz-T101 Tcr-T Cell Anal Carcinoma	HRYZ Biotech Co.	P1	CC (43)
Hryz-T101 Tcr-T Cell Penile Carcinoma	HRYZ Biotech Co.	P1	CC (43)
Hryz-T101 Tcr-T Cell Vulvar Carcinoma	HRYZ Biotech Co.	P1	CC (43)

Showing 2301 to 2325 of 9,928 assets

PreviousPage 93 of 398Next